BioCentury | Jan 11, 2020
Company News

Management Tracks: Wave CFO departs; plus Polaris, Turning Point, ADC, Relmada, Aravive, Affimed, Impel, Candel and more

...10 years, most recently as SVP of Celgene Global Health, as well as SVP at Wyeth...
BioCentury | May 21, 2019
Politics & Policy

SCOTUS decision a boon to biopharmas in failure-to-warn cases

...FDA's decision preempted state law, the high court maintained and clarified the precedent set by Wyeth...
...Writing for the majority in Merck , Justice Stephen Breyer said, "In a case like Wyeth...
...warn about newly discovered risks to patients unless barred by FDA," she said. "Maintaining the Wyeth...
BioCentury | May 4, 2019
Product Development

Amyloid: how did we get here and what can we learn?

...A) Elan Corp. plc sold its Alzheimer’s programs to Johnson & Johnson (NYSE:JNJ) in 2008; Wyeth...
...reported Population Pts Duration Cognition result Amyloid result Amyloid measure Completed? Elan Corp. plc / Wyeth...
BioCentury | Jan 11, 2019
Politics, Policy & Law

Supreme Court may reset FDA-State power balance

...is the direct result of controversies about the application of a prior Supreme Court case, Wyeth...
...on drug labels, many pharma lawyers incorrectly assumed after sharp questioning in oral arguments that Wyeth...
...were preempted and should be dismissed. The court’s “clear evidence” statement evoked the Supreme Court’s Wyeth...
BioCentury | Sep 1, 2018
Politics, Policy & Law

Back to School 2018: A pathway to Biopharma 3.0

As market and social forces continue to tighten around the biopharmaceutical industry, drug companies need to start evolving toward a new business model that both capitalizes on the potential of new technologies and accommodates society’s...
BioCentury | May 25, 2018
Finance

HKEX’s on-demand experts

...Ventures Strategic Advisor in life sciences at Sidley Austin; VP, clinical research Asia Pacific at Wyeth...
BioCentury | May 5, 2018
Strategy

Thinking globally, acting locally

...president, after serving since 2004 in a similar capacity at Pfizer, and before that at Wyeth...
BioCentury | May 4, 2018
Emerging Company Profile

Needling out Alzheimer’s

...the same target. The first clinically tested AD vaccine, AN-1792 from Elan Corp. plc and Wyeth...
BioCentury | May 3, 2018
Company News

Management tracks: Achillion, Sangamo

...New York, N.Y.) appointed Robert Essner as executive chairman. He was chairman and CEO of Wyeth...
BioCentury | May 1, 2018
Company News

Pfizer China GM Wu jumps to BeiGene

...Wu has over 17 years experience leading China operations for multinational companies including Pfizer, Wyeth...
Items per page:
1 - 10 of 2528
BioCentury | Jan 11, 2020
Company News

Management Tracks: Wave CFO departs; plus Polaris, Turning Point, ADC, Relmada, Aravive, Affimed, Impel, Candel and more

...10 years, most recently as SVP of Celgene Global Health, as well as SVP at Wyeth...
BioCentury | May 21, 2019
Politics & Policy

SCOTUS decision a boon to biopharmas in failure-to-warn cases

...FDA's decision preempted state law, the high court maintained and clarified the precedent set by Wyeth...
...Writing for the majority in Merck , Justice Stephen Breyer said, "In a case like Wyeth...
...warn about newly discovered risks to patients unless barred by FDA," she said. "Maintaining the Wyeth...
BioCentury | May 4, 2019
Product Development

Amyloid: how did we get here and what can we learn?

...A) Elan Corp. plc sold its Alzheimer’s programs to Johnson & Johnson (NYSE:JNJ) in 2008; Wyeth...
...reported Population Pts Duration Cognition result Amyloid result Amyloid measure Completed? Elan Corp. plc / Wyeth...
BioCentury | Jan 11, 2019
Politics, Policy & Law

Supreme Court may reset FDA-State power balance

...is the direct result of controversies about the application of a prior Supreme Court case, Wyeth...
...on drug labels, many pharma lawyers incorrectly assumed after sharp questioning in oral arguments that Wyeth...
...were preempted and should be dismissed. The court’s “clear evidence” statement evoked the Supreme Court’s Wyeth...
BioCentury | Sep 1, 2018
Politics, Policy & Law

Back to School 2018: A pathway to Biopharma 3.0

As market and social forces continue to tighten around the biopharmaceutical industry, drug companies need to start evolving toward a new business model that both capitalizes on the potential of new technologies and accommodates society’s...
BioCentury | May 25, 2018
Finance

HKEX’s on-demand experts

...Ventures Strategic Advisor in life sciences at Sidley Austin; VP, clinical research Asia Pacific at Wyeth...
BioCentury | May 5, 2018
Strategy

Thinking globally, acting locally

...president, after serving since 2004 in a similar capacity at Pfizer, and before that at Wyeth...
BioCentury | May 4, 2018
Emerging Company Profile

Needling out Alzheimer’s

...the same target. The first clinically tested AD vaccine, AN-1792 from Elan Corp. plc and Wyeth...
BioCentury | May 3, 2018
Company News

Management tracks: Achillion, Sangamo

...New York, N.Y.) appointed Robert Essner as executive chairman. He was chairman and CEO of Wyeth...
BioCentury | May 1, 2018
Company News

Pfizer China GM Wu jumps to BeiGene

...Wu has over 17 years experience leading China operations for multinational companies including Pfizer, Wyeth...
Items per page:
1 - 10 of 2528